Vitamin B12, Folic Acid, and Vitamin D Status in Women of Reproductive Age
Assessment of Serum Concentrations of Vitamin B12, Folic Acid, and Vitamin D in Women of Reproductive Age to Determine Recommended Supplementation Doses in the Preconception Period and During Pregnancy
1 other identifier
observational
360
1 country
1
Brief Summary
This cross-sectional observational study aims to assess serum concentrations of vitamin B12, folic acid, and vitamin D in women of reproductive age in Herzegovina. The study is led by Professor Vajdana Tomić, MD, PhD, who serves as the Principal Investigator, at the Faculty of Health Studies, University of Mostar, Bosnia and Herzegovina. The goal is to determine whether current international supplementation guidelines reflect the actual micronutrient status of this population. A total of 360 women aged 18-49 will be enrolled between December 2024 and December 2025 after providing informed consent. The findings will inform population-specific recommendations for micronutrient supplementation during the preconception period and pregnancy. The study will be conducted at the Faculty of Health Studies, University of Mostar, Bosnia and Herzegovina.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 20, 2024
CompletedFirst Submitted
Initial submission to the registry
July 25, 2025
CompletedFirst Posted
Study publicly available on registry
August 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedAugust 1, 2025
July 1, 2025
9 months
July 25, 2025
July 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Serum concentration of vitamin B12
Measured in serum samples using Alinity i immunoassay system.
At enrollment (single visit)
Serum concentration of folic acid
Measured in serum samples using Alinity i immunoassay system.
At enrollment (single visit)
Serum concentration of vitamin D
Measured in serum samples using Alinity i immunoassay system.
At enrollment (single visit)
Study Arms (1)
Women of Reproductive Age
This cohort includes women aged 18 to 49 years who are undergoing blood sampling for analysis of serum concentrations of vitamin B12, folic acid, and vitamin D. No interventions are administered. This is an observational, cross-sectional study.
Interventions
This is an observational study. No intervention will be administered. Participants will provide blood samples for micronutrient analysis.
Eligibility Criteria
This study includes approximately 360 women aged 18 to 49 years from the Herzegovina region who participate after providing written informed consent. All participants are being screened according to defined inclusion and exclusion criteria. The study focuses on assessing serum concentrations of vitamin B12, folic acid, and vitamin D to support the development of population-specific supplementation guidelines for the preconception period and pregnancy.
You may qualify if:
- Women of reproductive age (18-49 years)
- Informed consent obtained
You may not qualify if:
- diabetes (Type I or II)
- epilepsy
- oncological diseases, inflammatory bowel disease
- supplementation with vitamin B12, folic acid, or vitamin D within the last 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Mostar
Mostar, 88000, Bosnia and Herzegovina
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 25, 2025
First Posted
August 1, 2025
Study Start
December 20, 2024
Primary Completion
September 1, 2025
Study Completion
December 1, 2025
Last Updated
August 1, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to privacy concerns and institutional policy limitations. All data will be analyzed and presented in aggregate form only, without identifying individual participants.